# GenKOre

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genkore

- Industry: Biotechnology
- Headquarters: Daejeon, South Korea
- Website: www.genkore.com/
- Total disclosed funding: $15M
- Latest round: Series A (Oct 17, 2022)
- Investors on record: 6

## About

Based in Daegu, South Korea, and founded in 2019, GenKOre Co., Ltd. edits both plant and animal genes to improve health conditions. In October 2022, the firm raised KRW 17.1 billion from investors AJU IB Investment, Kiwoom Investment, SJ Investment Partners, STIC Ventures, and The Wells Investment. Returning investor Clairvoyant Ventures also participated in this round. 

The company offers gene editing for both plants and animals, which helps in improving health conditions. The firm provides genome editing technology which is a group of technology that provides the ability of scientists to change the DNA of organisms. Additionally, the company also offers a therapeutic approach.

The October 2022 funding will help the company to spur growth and R&D.

## Funding rounds

- Series A, Oct 17, 2022, $12M — AJU IB Investment, Kiwoom Investment, SJ Investment Partners, The Wells Investment, STIC Ventures, Clairvoyant Ventures
- Seed, Sep 30, 2019, $3M — Clairvoyant Ventures

## Investors

- Clairvoyant Ventures (https://capitalatlas.ai/funds/clairvoyant-ventures) — Seed, Series A
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series A
- Kiwoom Investment (https://capitalatlas.ai/funds/kiwoom-investment) — Series A
- SJ Investment Partners (https://capitalatlas.ai/funds/sj-investment-partners) — Series A
- The Wells Investment (https://capitalatlas.ai/funds/the-wells-investment) — Series A
- STIC Ventures (https://capitalatlas.ai/funds/stic-ventures) — Series A